政府R&D补助是否一定促进企业R&D投入?针对这一问题,本文以区分政府R&D补助方式作为切入点,从理论角度分析事前一次性R&D补助、补贴率方式R&D补助及事后奖励方式R&D补助对企业R&D投入的不同影响;并使用A股医药制造业上市公司2007~2013年面板数据进行实证分析。本文研究发现,只有补贴率方式和事后奖励方式R&D补助显著促进了企业R&D投入,其余补助方式对企业R&D不存在显著促进作用。对样本按产权特征进行分组后,我们发现对于非国有样本,补贴率方式和事后奖励方式R&D补助都显著促进R&D投入;而对于国有样本,所有类型补助对公司R&D投入皆无显著影响。本文的结论表明,政府应更多使用补贴率方式和事后奖励方式R&D补助;企业产权特征是政府补助时值得考虑的因素。
Whether the government R&D subsidies promote enterprises' R&D input? Distinguishing government R&D subsidies' types, this paper analyzes the three different subsidy ways' one-time payments in advance, subsidies by subsidy rate and reward afterwards influence on enterprises' R&D input. Using China' s Pharmaceutical manufacturing listed companies' 2007 - 2013 panel data, we empirical test these ways' different influence. The results show that R&D subsidies by subsidy rate and reward afterwards can significantly promote companies' R&D input. Grouping by companies' property characteristics,we find R&D subsidies by subsidy rate and by reward afterwards have a significant positive effect on R&D input for non-state-owned samples, and all subsidy ways don' t have significantly influence on companies' R&D input. This paper' s resuits suggest that government should more use subsidies by subsidy rate and by reward afterwards; and companies' property characteristics should be considered by government.